Sponsor:
Wake Forest University Health Sciences
Code:
NCT05696782
Conditions
Nonsmall Cell Lung Cancer Stage III
Unresectable Non-Small Cell Lung Carcinoma
Nonsmall Cell Lung Cancer, Stage II
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Durvalumab
the EORTC Core Quality of Life Questionnaire (EORTC QLQ-C30)
COPD Assessment Test (CAT)
Modified Medical Research Council (mMRC) dyspnea scale
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations